Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is N/A as of the fiscal period ended Thursday, December 31, 2020.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q4 FY2020 (2020-12-31): 656.29%.
RETURN ON EQUITY (ROE)
N/A
RETURN ON EQUITY (ROE) AVG TTM
N/A
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
153.35%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
HCA Healthcare, Inc.
Market Cap
$91.60B
Return on Equity (ROE)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$90.77B
Return on Equity (ROE)
11.06%
TTM Avg
13.69%
3Y Avg
14.71%
5Y Avg
14.93%
Market Cap
$80.01B
Return on Equity (ROE)
13.65%
TTM Avg
14.72%
3Y Avg
15.95%
5Y Avg
23.11%
Market Cap
$104.67B
Return on Equity (ROE)
N/A
TTM Avg
-189.06%
3Y Avg
-180.53%
5Y Avg
3473.86%
Market Cap
$106.77B
Return on Equity (ROE)
15.55%
TTM Avg
14.50%
3Y Avg
15.05%
5Y Avg
14.30%
Market Cap
$76.15B
Return on Equity (ROE)
15.05%
TTM Avg
11.32%
3Y Avg
12.19%
5Y Avg
12.83%
Market Cap
$65.30B
Return on Equity (ROE)
14.71%
TTM Avg
10.21%
3Y Avg
8.16%
5Y Avg
6.40%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HCA Healthcare, Inc. (HCA) | $91.60B | N/A | N/A | N/A | N/A |
| Elevance Health Inc. (ELV)vs › | $90.77B | 11.06% | 13.69% | 14.71% | 14.93% |
| GSK plc (GSK)vs › | $99.95B | 27.67% | 26.90% | 55.97% | 45.70% |
| Sanofi (SNY)vs › | $102.48B | 5.82% | 9.06% | 9.15% | 10.86% |
| Regeneron Pharmaceuticals, Inc. (REGN)vs › | $80.01B | 13.65% | 14.72% | 15.95% | 23.11% |
| McKesson Corporation (MCK)vs › | $104.67B | N/A | -189.06% | -180.53% | 3473.86% |
| Stryker Corporation (SYK)vs › | $106.77B | 15.55% | 14.50% | 15.05% | 14.30% |
| Cigna Corporation (CI)vs › | $76.15B | 15.05% | 11.32% | 12.19% | 12.83% |
| Boston Scientific Corporation (BSX)vs › | $65.30B | 14.71% | 10.21% | 8.16% | 6.40% |
| Medtronic plc (MDT)vs › | $119.48B | 10.41% | 9.71% | 8.51% | 8.44% |
ROE
N/A
ROA
11.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2020-12-31 | 656.29% |
| 2006-09-30 | 24.17% |
| 2006-06-30 | 26.50% |
| 2006-03-31 | 30.49% |
| 2005-12-31 | 29.28% |
| 2005-09-30 | 22.35% |
| 2005-06-30 | 22.36% |
| 2005-03-31 | 24.67% |
| 2004-12-31 | 28.27% |
| 2004-09-30 | 19.04% |
| 2004-06-30 | 20.81% |
| 2004-03-31 | 19.45% |
| 2003-12-31 | 21.45% |
| 2003-09-30 | 14.93% |
| 2003-06-30 | 13.49% |
